We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
The UK’s Vaccine Taskforce has secured early access to a vaccine produced by Valneva.
A deal has been reached for an intial 60 million doses with the option for a further 130 million if the vaccine is proven to be safe, effective and suitable.
This is a developing news story, more to follow.
Source: Read Full Article